Metagenomi Competitors and Similar CompaniesClear all

Metagenomi's competitors and similar companies include Eleusis, leadXpro, Engitix and Abterra Biosciences.
Metagenomi
Metagenomi
Metagenomi is a company that provides a metagenomics discovery platform.
Eleusis
Eleusis
Eleusis is a company developing the therapeutic potential of serotonin 2A receptor agonists.
leadXpro
leadXpro
leadXpro is a discovery company focusing on membrane protein drug targets.
Engitix
Engitix
Engitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform.
Abterra Biosciences
Abterra Biosciences
Abterra Biosciences (formerly Digital Proteomics) is a company engaged in antibody discovery and sequencing using NGS (next-generation sequencing) and mass spectrometry.
Founding Date
Founding Date
2018
Founding Date
2013
Founding Date
2015
Founding Date
2016
Founding Date
2009
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Emeryville, US HQ
Locations
London, GB HQ
New York, US
New York, US
Locations
Villigen, CH HQ
Locations
Cambridge, US HQ
London, GB
London, GB
Locations
San Diego, US HQ
Employees
Employees
223
Employees
19
Employees
N/A
Employees
542% increase
Employees
11

Funding

Total funding raised
Total funding raised
$ 74.9m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 6.4m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Eleusis
HQ
London, GB
Employees
19

Eleusis is a company developing the therapeutic potential of serotonin 2A receptor agonists.

View company
leadXpro
HQ
Villigen, CH

leadXpro is a discovery company focusing on membrane protein drug targets.

View company
Engitix
HQ
Cambridge, US
Employees
54↑ 2% increase

Engitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform.

View company
Abterra Biosciences
HQ
San Diego, US
Employees
11

Abterra Biosciences (formerly Digital Proteomics) is a company engaged in antibody discovery and sequencing using NGS (next-generation sequencing) and mass spectrometry.

View company